临床和实验洞察到NETosis在IgA脏病发作病原体中的作用
Gangan Wang1, Yixin Dong2, Xiangyu Qiao2
1Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
中性细胞细胞外陷 (NETs) 在IgA脏病 (IgAN) 中升高,并导致损伤. 抑制NETosis可以改善Igan的结果,这表明它是这种自身免疫性脏疾病的潜在治疗标.
科学领域:
- 免疫学 免疫学 免疫学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 病理学 病理学 病理学
背景情况:
- 中性粒细胞外细胞陷 (NETs) 涉及到自身免疫性疾病,但它们在IgA脏病 (IgAN) 中的作用尚不清楚.
- NETosis,NET形成的过程,有助于炎症和组织损伤.
研究的目的:
- 为了调查NETosis在IgA脏病 (IgAN) 病原发生过程中的参与.
- 评估NETosis对IGAN中损伤和中细胞功能的影响.
- 评估NETosis抑制作为Igan的潜在治疗策略.
主要方法:
- 从Igan患者的外周血液单核细胞 (PBMC) 的RNA测序,以确定与NETosis相关的途径.
- 建立Igan小鼠模型并使用NETosis抑制剂 (GSK484) 进行治疗.
- 试验室试验评估NETosis对介质细胞和炎症性细胞因子释放的影响.
主要成果:
- 在Igan患者中观察到NETosis标记物 (CitH3,MPO,中性粒细胞弹性酶) 的血清水平升高,与Gd-IgA1水平相关.
- 在IGAN小鼠中抑制NETosis减少了蛋白尿,增加了血清白蛋白,并降低了中增殖.
- 在体外,NETosis增强了TNF-α从介质细胞中的释放,NETosis抑制调节了PPAR信号通路.
结论:
- 在IgA脏病中,NETosis被上调调节,并通过炎症性细胞因子释放为其病变产生贡献.
- 抑制NETosis证明了治疗潜力,改善了IGAN中的临床和病理结果.
- 向NETosis提供了一个有前途的策略来管理IgA病.
更多相关视频
05:39Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
Published on: July 8, 2020
11:32Real-Time, High-Throughput Microscopic Quantification of Human Neutrophil Extracellular Trap Release and Assessing the Pharmacology of Antagonists
Published on: October 18, 2024
相关概念视频
Nephrotic Syndrome I : Introduction
Acute Kidney Injury II: Pathophysiology
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Nephrotic Syndrome II : Assessment and Medical Management
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
